Charles River Laboratories International CRL
NYSE CRL
$302.65 +3.64 (+1.22%)
As of: Oct 14, 2026 · 3:08 PM EDT

Charles River Laboratories International (CRL) Current Deferred Revenue (2009 - 2026)

Updated

Charles River Laboratories International's Current Deferred Revenue came in at $203.04 million for Q2 2026, down 24.3% from $268.34 million a year earlier but up 4.5% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Current Deferred Revenue (2009 - 2026) Analysis & Trends

At the end of FY2025, Charles River Laboratories International's Current Deferred Revenue was $210.42 million, down 15.3% from FY2024.

  • Current Deferred Revenue carries a five-year compound annual growth rate of 0.2% (FY2020 to FY2025).
  • Going back by year, Current Deferred Revenue was $248.32 million in FY2024 (+2.7%), $241.82 million in FY2023 (-8.5%), $264.26 million in FY2022 (+20.3%) and $219.7 million in FY2021 (+5.7%).
  • The five-year range for quarterly Current Deferred Revenue is $194.33 million (Q1 2026) to $268.34 million (Q2 2025).
  • Year-over-year, Current Deferred Revenue has declined for four consecutive quarters, with an average decline of 7.3% over the last eight quarters.
  • The fastest year-over-year change in Current Deferred Revenue over five years came in Q4 2022 (growth of 20.3%), and the weakest in Q2 2026 (a decline of 24.3%).
  • Business Quant data shows CRL's Current Deferred Revenue at $194.33 million (Q1 2026), $210.42 million (Q4 2025) and $237.73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.47 Bn 35.18 Bn 1.44 Bn
2 Medpace Holdings 17.38 Bn 15.44 Bn 201.64 Mn
3 Charles River Laboratories International 14.51 Bn 13.70 Bn 363.37 Mn
4 Icon 13.19 Bn 10.30 Bn 479.29 Mn
5 Fortrea Holdings 2.02 Bn 1.39 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 711.74 Mn -50.34 Mn 18.44 Mn
7 Evotec SE 504.32 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 64.47 Mn 28.12 Mn 1.61 Mn
10 Natural Alternatives International 6.84 Mn -21.24 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 203.04 Mn
Mar 28, 2026 194.33 Mn
Dec 27, 2025 210.42 Mn
Sep 27, 2025 237.73 Mn
Jun 28, 2025 268.34 Mn
Mar 29, 2025 250.46 Mn
Dec 28, 2024 248.32 Mn
Sep 28, 2024 251.97 Mn
Jun 29, 2024 247.18 Mn
Mar 30, 2024 256.38 Mn
Dec 30, 2023 241.82 Mn
Sep 30, 2023 250.49 Mn
Jul 1, 2023 257.40 Mn
Apr 1, 2023 262.23 Mn
Dec 31, 2022 264.26 Mn
Sep 24, 2022 251.47 Mn
Jun 25, 2022 242.08 Mn
Mar 26, 2022 228.26 Mn
Dec 25, 2021 219.70 Mn
Sep 25, 2021 221.73 Mn
API Access

Charles River Laboratories International Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CRL&period=max&api_key=YOUR_API_KEY